Ten weeks after CS or metformin treatment, SOD, GPX, and CAT activity levels were raised, and MDA level was lowered (CS vs. T1DM, p < 0.01; Met vs. T1DM, p < 0.01) (Figure 5). The gene discussed is CAT; the disease is type 1 diabetes mellitus.